US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 13, 2020 (6 years ago)

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

What was recalled

Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

Recalling firm
Sun Pharmaceutical Industries, Inc.
NDC code
63304-615-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1032-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Doxycycline recalls

See all